Cytogenetic effects of 3-chloro-4-(dichloromethyl)-5-hydroxy-2(5H)-furanone (MX) in rat peripheral lymphocytes in vitro and in vivo. 1993

K Jansson, and J Mäki-Paakkanen, and S L Vaittinen, and T Vartiainen, and H Komulainen, and J Tuomisto
Division of Environmental Health, National Public Health Institute, Kuopio, Finland.

3-Chloro-4-(dichloromethyl)-5-hydroxy-2(5H)-furanone (MX) is a potent direct-acting Salmonella mutagen found in wood pulp chlorination effluents and chlorinated drinking water. In cultured rat peripheral lymphocytes, MX induced significant dose-related increases in sister-chromatid exchanges (SCEs) and chromosome aberrations at doses of 20-60 micrograms/ml and of 60-80 micrograms/ml, respectively. MX produced primarily chromatid-type as opposed to chromosome-type aberrations. The peripheral lymphocytes of male and female rats exposed to MX by gavage 5 days a week for 14-18 weeks showed significant dose-related increases in SCEs at both levels of exposure (30 and 45-75 mg/kg) in both sexes. The present results demonstrate for the first time that MX is genotoxic in vivo.

UI MeSH Term Description Entries
D008214 Lymphocytes White blood cells formed in the body's lymphoid tissue. The nucleus is round or ovoid with coarse, irregularly clumped chromatin while the cytoplasm is typically pale blue with azurophilic (if any) granules. Most lymphocytes can be classified as either T or B (with subpopulations of each), or NATURAL KILLER CELLS. Lymphoid Cells,Cell, Lymphoid,Cells, Lymphoid,Lymphocyte,Lymphoid Cell
D008297 Male Males
D009153 Mutagens Chemical agents that increase the rate of genetic mutation by interfering with the function of nucleic acids. A clastogen is a specific mutagen that causes breaks in chromosomes. Clastogen,Clastogens,Genotoxin,Genotoxins,Mutagen
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D002869 Chromosome Aberrations Abnormal number or structure of chromosomes. Chromosome aberrations may result in CHROMOSOME DISORDERS. Autosome Abnormalities,Cytogenetic Aberrations,Abnormalities, Autosome,Abnormalities, Chromosomal,Abnormalities, Chromosome,Chromosomal Aberrations,Chromosome Abnormalities,Cytogenetic Abnormalities,Aberration, Chromosomal,Aberration, Chromosome,Aberration, Cytogenetic,Aberrations, Chromosomal,Aberrations, Chromosome,Aberrations, Cytogenetic,Abnormalities, Cytogenetic,Abnormality, Autosome,Abnormality, Chromosomal,Abnormality, Chromosome,Abnormality, Cytogenetic,Autosome Abnormality,Chromosomal Aberration,Chromosomal Abnormalities,Chromosomal Abnormality,Chromosome Aberration,Chromosome Abnormality,Cytogenetic Aberration,Cytogenetic Abnormality
D005260 Female Females
D005663 Furans Compounds with a 5-membered ring of four carbons and an oxygen. They are aromatic heterocycles. The reduced form is tetrahydrofuran. Tetrahydrofurans
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012854 Sister Chromatid Exchange An exchange of segments between the sister chromatids of a chromosome, either between the sister chromatids of a meiotic tetrad or between the sister chromatids of a duplicated somatic chromosome. Its frequency is increased by ultraviolet and ionizing radiation and other mutagenic agents and is particularly high in BLOOM SYNDROME. Chromatid Exchange, Sister,Chromatid Exchanges, Sister,Exchange, Sister Chromatid,Exchanges, Sister Chromatid,Sister Chromatid Exchanges
D017208 Rats, Wistar A strain of albino rat developed at the Wistar Institute that has spread widely at other institutions. This has markedly diluted the original strain. Wistar Rat,Rat, Wistar,Wistar Rats

Related Publications

K Jansson, and J Mäki-Paakkanen, and S L Vaittinen, and T Vartiainen, and H Komulainen, and J Tuomisto
November 1995, Toxicology letters,
K Jansson, and J Mäki-Paakkanen, and S L Vaittinen, and T Vartiainen, and H Komulainen, and J Tuomisto
June 1993, Toxicology letters,
K Jansson, and J Mäki-Paakkanen, and S L Vaittinen, and T Vartiainen, and H Komulainen, and J Tuomisto
December 1995, Mutation research,
K Jansson, and J Mäki-Paakkanen, and S L Vaittinen, and T Vartiainen, and H Komulainen, and J Tuomisto
April 1998, Journal of toxicology and environmental health. Part A,
K Jansson, and J Mäki-Paakkanen, and S L Vaittinen, and T Vartiainen, and H Komulainen, and J Tuomisto
June 1997, Journal of the National Cancer Institute,
K Jansson, and J Mäki-Paakkanen, and S L Vaittinen, and T Vartiainen, and H Komulainen, and J Tuomisto
February 2002, Environmental health perspectives,
K Jansson, and J Mäki-Paakkanen, and S L Vaittinen, and T Vartiainen, and H Komulainen, and J Tuomisto
April 2003, Birth defects research. Part B, Developmental and reproductive toxicology,
K Jansson, and J Mäki-Paakkanen, and S L Vaittinen, and T Vartiainen, and H Komulainen, and J Tuomisto
September 1997, Chemico-biological interactions,
K Jansson, and J Mäki-Paakkanen, and S L Vaittinen, and T Vartiainen, and H Komulainen, and J Tuomisto
December 2002, Journal of toxicology and environmental health. Part A,
K Jansson, and J Mäki-Paakkanen, and S L Vaittinen, and T Vartiainen, and H Komulainen, and J Tuomisto
January 1999, Reviews on environmental health,
Copied contents to your clipboard!